151 related articles for article (PubMed ID: 22398807)
1. Breast cancer in focus: treatment options for triple-negative metastatic breast cancer.
O'Shaughnessy JA
Clin Adv Hematol Oncol; 2012 Jan; 10(1):43-5. PubMed ID: 22398807
[No Abstract] [Full Text] [Related]
2. Metastatic triple-negative breast cancer.
Rakha EA; Chan S
Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):587-600. PubMed ID: 21524569
[TBL] [Abstract][Full Text] [Related]
3. Directed therapy of subtypes of triple-negative breast cancer.
Carey LA
Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer and brain metastases.
Sait B; Cinar E; Altundag K
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):84. PubMed ID: 19751969
[No Abstract] [Full Text] [Related]
5. Triple-negative breast cancer.
Oncology (Williston Park); 2010 Oct; 24(10 Suppl):40a. PubMed ID: 21275325
[No Abstract] [Full Text] [Related]
6. Pattern of metastatic spread in triple-negative breast cancer.
Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
Breast Cancer Res Treat; 2009 May; 115(2):423-8. PubMed ID: 18543098
[TBL] [Abstract][Full Text] [Related]
7. [Changing behavior of estrogen and progesterone receptors with metastasis or recurrence of breast cancer].
Morimoto K; Koh M; Yamamoto A; Tamura K; Yamamoto K; Yamamoto K; Suehiro S
Gan To Kagaku Ryoho; 2006 Jul; 33(7):925-9. PubMed ID: 16835481
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].
Zhang P; Xu BH; Ma F; Li Q
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):128-31. PubMed ID: 20403244
[TBL] [Abstract][Full Text] [Related]
9. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ
Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer: a short review.
Elias AD
Am J Clin Oncol; 2010 Dec; 33(6):637-45. PubMed ID: 20023571
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of triple-negative breast cancer.
Arslan C; Dizdar O; Altundag K
Expert Opin Pharmacother; 2009 Sep; 10(13):2081-93. PubMed ID: 19640211
[TBL] [Abstract][Full Text] [Related]
12. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
Voduc D; Nielsen TO
Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
14. From the guest editor: Triple-negative breast cancer.
Hudis CA
Cancer J; 2010; 16(1):10-1. PubMed ID: 20164684
[No Abstract] [Full Text] [Related]
15. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
Mehta RS
J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
[No Abstract] [Full Text] [Related]
16. Molecular stratification of triple-negative breast cancers.
Perou CM
Oncologist; 2011; 16 Suppl 1():61-70. PubMed ID: 21278442
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer: breast cancer research in evolution.
Eng-Wong J; Hunsberger S; Zujewski JA
Breast Dis; 2010; 32(1-2):1-4. PubMed ID: 21778576
[No Abstract] [Full Text] [Related]
18. Are triple-negative and basal-like breast cancer synonymous?
Rakha E; Ellis I; Reis-Filho J
Clin Cancer Res; 2008 Jan; 14(2):618; author reply 618-9. PubMed ID: 18223240
[No Abstract] [Full Text] [Related]
19. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
20. Treatment of triple negative breast cancer (TNBC): current options and future perspectives.
De Laurentiis M; Cianniello D; Caputo R; Stanzione B; Arpino G; Cinieri S; Lorusso V; De Placido S
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S80-6. PubMed ID: 21129616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
